- 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea
- BRD-K34776109-001-16-6
- HMS2090K18
- HMS3677K06
- Q-201158
- GLIMEPIRIDE [USP IMPURITY]
- G0395
- BRD-K34776109-001-14-1
- Amaryl
- NCGC00016960-07
- Glimepiride,(S)
- AKOS015969663
- SL-NH2 Trifluoroacetic Acid Salt (1:2)
- Tox21_110713_1
- MLS003915622
- GLIMEPIRIDE IMPURITY A [EP IMPURITY]
- EN300-19873446
- Trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
- HMS3372O07
- NSC 759809
- AB00513874-09
- GLIMEPIRIDE [ORANGE BOOK]
- GLIMEPIRIDE [EP MONOGRAPH]
- AB00513874
- CAS-93479-97-1
- Glimepirid
- GLIMEPIRIDE [VANDF]
- AKOS015894919
- Glimepiride- Bio-X
- gimepiride
- CS-0165191
- SW196369-4
- HOE 490
- Amaryl (TN)
- HMS3413K06
- SCHEMBL16084
- glimepiride
- AB07644
- SR-05000001508-2
- Glista OD
- D00593
- Q27253874
- 3-ethyl-4-methyl-N-[2-(4-{[(4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- GLIMEPIRIDE [USP-RS]
- Glimer
- HOE490
- MLS006011260
- HMS1570C03
- BDBM50237590
- Glimepiride; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide; Amaryl; Glimperide; HOE 490; trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide
- SPBio_002602
- HMS2097C03
- SR-05000001508-3
- 3-ethyl-4-methyl-N-(4-(N-((1r,4r)-4-methylcyclohexylcarbamoyl)
- DB00222
- BG164507
- DUETACT COMPONENT GLIMEPIRIDE
- SCHEMBL14371714
- Glymepirid
- NCGC00371061-06
- NCGC00016960-05
- Glimepiridum
- GLIMEPIRIDE [EMA EPAR]
- BPBio1_000751
- NC00406
- 93479-97-1
- 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- 3-ETHYL-4-METHYL-N-(4-(N-((1R,4R)-4-METHYLCYCLOHEXYLCARBAMOYL)SULFAMOYL)PHENETHYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
- Tox21_110713
- C07669
- Glimepiride, United States Pharmacopeia (USP) Reference Standard
- NCGC00016960-02
- Glimepiride, >=98% (HPLC), solid
- GLIMEPIRIDE [USAN]
- Glimepiride Impurity A
- 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide
- 3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- BRD-K42693031-001-01-8
- Oprea1_382896
- SMR001550123
- AB00513874_11
- Glimepiride, cis-
- UNII-24T6XIR2MZ
- DTXSID20861130
- 1H-Pyrrole-1-carboxamide, 2,5-dihydro-3-ethyl-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-
- NCGC00181757-01
- Solosa
- 3-Ethyl-4-methyl-N-(4-(N-((rel-(1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide
- 3-ethyl-4-methyl-N-(4-(N-(((1r,4r)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- Glimepirida
- HMS3394L03
- Pharmakon1600-01504915
- NCGC00161404-01
- CCG-101156
- Glimepiridum [Latin]
- NCGC00371061-02
- HMS2052L03
- NS00004860
- GLIMEPIRIDE [USP MONOGRAPH]
- Glimepiride, British Pharmacopoeia (BP) Reference Standard
- s1344
- Q425027
- 6KY687524K
- 1-[[4-[2-[[(3-Ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulphonyl]-3-(cis-4-methylcyclohexyl)urea (cis-Glimepiride)
- 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car
- boxamide
- AC-476
- Z1501475009
- NSC759809
- HY-B0104R
- 1H-PYRROLE-1-CARBOXAMIDE, 3-ETHYL-2,5-DIHYDRO-4-METHYL-N-(2-(4-(((((CIS-4-METHYLCYCLOHEXYL)AMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-OXO-
- 1-((4-(2-(((3-ETHYL-4-METHYL-2-OXO-2,3-DIHYDRO-1H-PYRROL-1-YL)CARBONYL)AMINO)ETHYL)PHENYL)SULFONYL)-3-(CIS-4-METHYLCYCLOHEXYL)UREA
- GLIMEPIRIDE [INN]
- Glimepiride, European Pharmacopoeia (EP) Reference Standard
- Amarel
- 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea
- Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard
- Sugral
- STL451059
- SCHEMBL8738802
- UNII-6KY687524K
- CHEMBL1481
- Glimepiride [USAN:USP:INN:BAN]
- SMR000466368
- Glimepirida [Spanish]
- Prestwick3_000651
- NCGC00016960-04
- BSPBio_000681
- DTXCID3020675
- CHEBI:5383
- BCP05331
- 3-ethyl-4-methyl-N-[2-(4-{[(cis-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-car boxamide
- GLIMEPIRIDE CIS-ISOMER
- HY-B0104
- HMS3714C03
- Glemax
- BCP9000728
- Ristocetin Sulfate; Ristomycin Sulfate
- Glimepiride for system suitability
- Prestwick2_000651
- KS-5238
- cis-Glimepiride
- 3-ethyl-4-methyl-N-(4-(N-(((1s,4s)-4-methylcyclohexyl)carbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide? (Glimepiride Impurity pound(c)
- NCGC00016960-03
- CHEMBL149223
- Prestwick1_000651
- MLS000759495
- 261361-60-8
- Glimepride
- BRD-K34776109-001-15-8
- SR-05000001508
- DTXSID5040675
- MLS001401419
- 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans- 4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-
- Niddaryl
- NSC813217
- NCGC00016960-01
- Amaryl, Glista OD
- MLS001076674
- AB00513874-06
- 24T6XIR2MZ
- SCHEMBL26496475
- NCGC00161404-02
- sulfamoyl)phenethyl)-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide
- GLIMEPIRIDE [JAN]
- BRD-K34776109-001-03-4
- SR-05000001508-1
- 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-(2-(4-(((((4-methylcyclohexyl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-oxo-, trans-
- 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro
- HMS2235L07
- GLIMEPIRIDE [MI]
- trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
- CCRIS 7083
- AB00513874_10
- AB00513874-08
- CS-1844
- 3-Ethyl-4-Methyl-N-[2-(4-{[(Cis-4-Methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-Oxo-2,5-Dihydro-1h-Pyrrole-1-Carboxamide', "N'-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-N-(4-methylcyclohexyl)carbamimidic acid", "N-[4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl]-N'-4-methylcyclohexylurea", 'trans-1-(4-(2-(3-ethyl-4-Me-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea
- α-Tocopherol
- NSC-813217
- Roname
- Glimepiride (JP18/USP/INN)
- SCHEMBL16086
- SCHEMBL14965363
- 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
- Glimepiride 100 microg/mL in Acetonitrile
- Endial
- HMS3654F17
- BRN 5365754
- MFCD00878417
- CPD000466368
- CHEBI:92609
- Glimepiride (Standard)
- STL453194
- GLIMEPIRIDE [WHO-DD]
- HMS3269A09
- NSC-759809
- Glorion
- Hoe-490
- GTPL6820
- Prestwick0_000651
- GLIMEPIRIDE [MART.]
- 684286-46-2
- Ristomycin Monosulfate (90%)
|